Rovida Advisors Inc. Johnson & Johnson Transaction History

Rovida Advisors Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $37.7 Million - $42.8 Million	-238,200 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$128.81 - $155.51 $30.7 Million - $37 Million	238,200 New	238,200 $33.4 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $24.9 Million - $34.5 Million	-224,100 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $5.1 Million - $5.86 Million	40,000 Added 21.73%	224,100 $32.7 Million
Q3 2019 Nov 08, 2019	BUY	$126.95 - $142.14 $1.98 Million - $2.22 Million	15,600 Added 9.26%	184,100 $23.8 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $21.8 Million - $22.8 Million	168,500	168,500 $21.9 Million

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Rovida Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Rovida Advisors Inc. with notifications on news.